Document is current
Any future updates will be listed below
-
Authors
Liang, Jiaxin
Vitale, Tevis https://orcid.org/0000-0002-0479-128X
Zhang, Xixi
Jackson, Thomas D.
Yu, Deyang
Jedrychowski, Mark
Gygi, Steve P. https://orcid.org/0000-0001-7626-0034
Widlund, Hans R. https://orcid.org/0000-0002-7506-2447
Wucherpfennig, Kai W. https://orcid.org/0000-0002-1829-302X
Puigserver, Pere https://orcid.org/0000-0002-0884-2718
- License Information
-
More Information
Article History
Received: 2 October 2023
Accepted: 10 December 2024
First Online: 17 January 2025
Competing interests
: K.W.W. serves on the scientific advisory boards of TScan Therapeutics, Bisou Bioscience Company, DEM BioPharma, Solu Therapeutics and Nextechinvest, and he receives sponsored research funding from Novartis. K.W.W. is a co-founder, stockholder and advisory board member of Immunitas Therapeutics, a biotech company. The other authors declare no competing interests.
